lorazepam has been researched along with Hypokalemia in 1 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Sotos, P | 1 |
| López-Álvarez, J | 1 |
| López Arcas-Calleja, P | 1 |
| García-Tercero, RM | 1 |
| Del Yerro-Álvarez, MJ | 1 |
1 other study available for lorazepam and Hypokalemia
| Article | Year |
|---|---|
Mixed etiology catatonia.
Topics: Catatonia; Cholecystitis, Acute; Humans; Hypokalemia; Hyponatremia; Lorazepam; Male; Middle Aged; Pr | 2020 |